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In vitro exposure of mouse thymocytes to complexes of polyadenylic:polyuridylic
acid (poly A:U) effected, within 6 h, the release of soluble factor(s) capable of
nonspecifically enhancing IgM and IgG plaque-forming cells (PFCs) in in vitro
primary and secondary spleen cell responses to burro erythrocytes. Poly A:U
stimulation was, most likely, polyclonal, since production of soluble factor(s)
occurred in the absence of antigen and in serum-free culture media. Poly A:U-
induced soluble factor(s) were not capable of substituting for T cells but were
dependent on T cells for the expression of PFC enhancement. These data support
the hypothesis that the mechanism of poly A:U's adjuvant action is polyclonal
stimulation of T cells, causing early induction and release of nonspecific, soluble
PFC-enhancing factor(s).
A. G. Johnson, Department of Microbiology, University of Michigan Medical
School, 6643 Medical Sciences Bldg. II, Ann Arbor, Ml 48109, USA
Complexes of polyadenylic-polyuridylic acid
(poly A:U) have been shown to be effective
adjuvants to both limbs of the immune re-
sponse (18). Although several cells are af-
fected by this adjuvant, a major effect is ex-
erted on the T cell. This was most clearly
manifested when the number of T cells was
diminished by thymectomy or anti-lymphocyte
globulin (3). It seemed likely that this ad-
juvant amplified the efficiency of residual T
cells. Indirect evidence supporting this view
was gained by means of experiments showing
that vinblastine, a drug that inhibits cell divi-
sion, reduced antibody synthesis in poly A:U-
treated mice by 90% 6 h before mice receiving
only antigen (4). Direct evidence that poly
A:U was acting on thymocytes was achieved
through the use of the irradiated mouse model
(3). In these experiments, in which either
thymocytes or bone marrow cells were selec-
tively incubated in vitro with or without poly
A:U before transfer, a tenfold increase in ro-
sette-forming cells occurred in mice receiving
thymocytes incubated with poly A:U. Further-
more, by reducing the number of thymocytes
to 40,000, an amount far below the minimal
threshold number necessary to act as helper
cells for antibody synthesis, a response was
elicited after incubation with poly A:U, again
suggesting amplification of T-cell function. B
cells selectively exposed to poly A;U in a simi-
lar manner did not increase their activity to
form rosettes, although polynucleotides have
been shown to be mitogenic for these cells (22,
23). In addition, low numbers of thymocytes
incubated with poly A:U in vitro reconstituted
the antibody response of nude mouse spleen
cell cultures, whereas normal control thymo-
cytes did not (5).
Although the experiments suggested that
poly A:U acted by stimulating division of T
lymphocytes, extensive study indicated that this
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adjuvant was not mitogenic for thymus cells
over a wide dose range (16). In addition, poly
A:U was only weakly mitogenic for spleen
cells when 1-5 /j,g was given intravenously to
normal or cortisone-treated Balb mice. Simi-
larly, only a doubling of control values was
evident in vitro when poly A:U was added to
cultures of spleen cells from normal or corti-
sone-treated mice. Thus, a weak mitogenic
effect of poly A:U appeared to be exerted on
peripheral T cells, but there was no effect on
thymocytes per se (16). Consequently, we have
further studied the mechanism of the profound
adjuvant action of poly A:U. Since T cells
have been shown to be capable of producing
soluble factors that enhance antibody responses
in vivo and in vitro after antigen stimulation (1,
12, 13, 21, 24, 27, 31), we tested the hypothe-
sis that the observed thymocyte helper activity
might be mediated through the release of a
soluble factor(s), the secretion of which can
be enhanced or increased in amount by poly
A:U action on T cells. The experimental evi-
dence presented here supports this hypothesis.
MATERIALS AND METHODS
Experimental animals. (C57B1/6 X C3Hf)Fi
hybrids were purchased from Microbiological
Associates, Bethesda, Md., USA, or raised in
our laboratory colony from inbred C57B1/6
female and C3Hf male parents obtained from
Microbiological Associates. Balb/aj mice were
inbred in our laboratory colony. Mice were age-
and sex-matched for each experiment. Nude
mice on a Balb/c background were a gift of
Dr. Norman Reed, Montana State University,
and were used at 10-12 weeks of age as spleen
cell donors. (C57B1/6 X C3Hf)Fi and Balb/aj
mice used for donors of thymocytes were killed
at 4-6 weeks of age, whereas those used as
spleen cell donors were killed at 12-20 weeks
of age.
Antigens. Sheep erythrocytes (SRBC) were
obtained by monthly bleedings of a single
sheep donor maintained in the University of
Michigan School of Public Health and were
stored in 50% Alsever's solution at 4°C for
4 weeks before use. Burro erythrocytes (BRBC)
were obtained from Colorado Serum Co.,
Denver, Colo., as sterile burro blood in
Alsever's solution. They were stored at 4°C
and used at 2-7 weeks of age. Before use,
SRBCs and BRBCs were washed three times in
Moller's modified balanced salt solution (MSS)
(6) and resuspended in the appropriate men-
strum to yield approximately 2.4 X 10^ RBC/
ml.
Homopolyribonticleotides. Polyadenylic acid
(lots 67, 77, 81) and polyuridylic acid (lots
72, 77, 91) were purchased as the potassi-
um and ammonium salts, respectively, from
Miles Laboratories Research Products Division,
Kankakee, 111. Tritium-labeled polyadenylic acid
(lot 13) was obtained from Miles Laboratories
in 50% ethanol solution and had a specific ac-
tivity of 19.1 AiCi/mg polymer. The homoribo-
polymers were dissolved in phosphate-buffered
saline (PBS), pH 7.2, at a concentration of not
less than 5 mg/ml and sterilized by filtration
through a filter of 0.22-;ixm pore size (Milli-
pore Corp., Bedford, Mass.). Radiolabeled
polyadenylic acid was not filter-sterilized. Poly
A:U complexes were prepared by aseptically
combining equal amounts of the individual
homoribopolymers at a concentration not less
than 5 mg/ml (final concentration of each
polymer, 2.5 mg,ml). The mixture was allowed
to complex for at least 10 min at room tem-
perature, and dilutions were made in PBS to
yield the desired concentrations. Sterile prep-
arations of the homoribopolymers were stored
at -20°C, whereas complexed poly A:U was
stored at 4°C.
Lipopolysaccharide. Lipopolysaccharide (LPS)
from Serratia marcescens, prepared by the
Boivin procedure, was a gift of Dr. A. No-
wotny. Temple University, Philadelphia, Pa.
Antisera. Anti-theta antisera, anti-Thy 1.2,
were prepared by the method of Reif & Allen
(20). The 50% cytotoxicity titer against Fi
thymocytes was 1:600, both by siCr release and
trypan blue determination. A dilution of 1:50
or less was used routinely, which killed 97%
of thymocytes. All anti-theta activity was re-
moved by absorption with C3H brain cells.
Background cytotoxicity levels with anti-theta
antiserum and thymus cells alone were routinely
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5% or less by both techniques and were below
the cytotoxicity levels of cells incubated alone.
Rabbit anti-mouse IgG facilitating indirect
plaque-forming cells (PFC) was prepared by
Dr. Carl Pierce, Harvard Medical School,
Boston, Mass.
Complement. Complement (GPC) was ob-
tained from guinea pigs that were ether-anes-
thetized and bled by heart puncture. GPC to
be used for PFC assay was absorbed twice for
30 min with RBCs and immediately frozen at
-70°C in multiple tubes for individual experi-
ments. GPC to be used for cell depletion and
cytotoxicity assays was absorbed with agarose
and mouse spleen cells. All complement sera
were thawed only once before use and had a
cytotoxicity titer of 1:128-1:256 as determined
by titration with (C57B1/6 X C3Hf)Fi thymo-
cytes and anti-theta antiserum using the trypan
blue cytotoxicity assay. Background cytotoxicity
of GPC without anti-theta antiserum was negli-
gible.
Cell preparations. Thymus and spleens were
aseptieally removed from mice killed by cervical
dislocation, kept in MSS on ice, and teased
apart, and the large debris was removed after
being allowed to settle. The cells in suspension
were pelleted by centrifugation for 10 min at
200 g at 6°C. Viability was determined by
trypan blue dye exclusion and was routinely
greater than 95%.
In vitro culture methods. Culture conditions
were essentially those of Mishell & Dutton
(19) with the addition of lOmM Hepes and
5 X lO^M 2-mercaptoethanol. Culture me-
dium was supplemented with heat-inactivated
fetal calf serum (FCS) at 10% final concen-
tration when appropriate (Reheis, Lot 22803,
Armour Pharmaceutical Co., Phoenix, Ariz.).
Cells were cultured at a density of 10''/ml in
35 X 10-mm plastic culture dishes. Where
appropriate, lO'̂  SRBC or BRBC were added
per dish as antigen. Culture dishes were in-
cubated in a gas-tight humidified chamber con-
taining 7% O;2, 10% CO2, and 83% N2 and
were rocked at approximately 7 cycles/min at
37°C.
Antibody-forming cell assay. Plaque-forming
cells were assayed by the local hemolysis-in-gel
technique of Jerne & Nordin as modified by
Coutinho et al. (7). Indirect (IgG) PFCs were
determined by plating a second sample of a
given cell suspension using GPC that contained
rabbit anti-mouse IgG (1:100 final dilution in
GPC). Since the facilitating antisera caused no
inhibition of the IgM PFCs during the assay,
the number of IgG PFCs was determined
directly by subtraction of total direct PFCs
from total indirect PFCs. After correction for
viable recovered cells, logio PFCs were calcu-
lated. To determine the level of confidence at
which two values were significantly different,
the mean + standard error for each group
was calculated from the results of three nor-
malized experiments and compared using
Student's / test. Two groups were considered
significantly different when P was less than
0.05. Normalization was carried out by setting
the PFC response to antigen alone at 100 PFC/
10^ viable recovered cells and adjusting all
other values in the same experiment according-
ly. Subsequently, several experiments could be
pooled for statistical evaluation. This procedure
was adopted because antigen-induced responses
to BRBC were reproducibly in the range of
50-150 PFC/10* viable recovered cells.
Preparation of supernatant fluids. Lympho-
cytes were incubated for 10-30 min in FCS-
free culture media (10'̂  cells/ml) with or
without poly A:U in plastic centrifuge tubes in
a shaking 37°C water bath. After incubation,
cell mixtures were immediately washed four
times and centrifuged at 200 g for 10 min at
6°C after each wash. After the washing, cells
were resuspended in fresh FCS-free culture
media and cultured for 0—24 h (usually 6 h)
under standard culture conditions. Supernatant
fluids were decanted into glass centrifuge tubes
and intact cells pelleted at 200 g for 10 min
at 6°C. Any remaining large particulate matter
was removed by centrifugation at 20,200 g for
20 min at 6°C. Supernatant fluids were steri-
lized by filtration through a Millipore mem-
brane of 0.22-ju,m pore size and assayed im-
mediately. Any remaining fluid was stored at
4°C.
Assay of supernatant fluids. Supernatant
fluids were assayed for PFC-enhancing activity
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* Normal Fi thymocytes (lO'/ml) were incubated with 50 /ig/ml poly A:U for 90 min, washed four times,
and cultured for 24 h. Supernatant fluids were added to cultures of normal Fi spleen cells at a 1:4 final
dilution with sheep erythrocytes (SRBC) as antigen on day 0. Plaque-forming cells (PFCs) were assayed
on day 4. Antilog PFC values are presented in parentheses.
t As above, except that the thymocytes were incubated with poly A:U for 10 min and cultured for 6 h. Burro
erythrocytes (BRBC) were used as antigen in this experiment.
in Fi, Balb/aj, or Balb/c nu/nu spleen cell cul-
tures. Triplicate cultures were prepared in FCS
containing culture media at a density of 10^
cells/ml and maintained under standard culture
conditions. Supernatant fluids were added on
day 0 at a 1:4 final dilution (0.25 ml super-
natant fluid/1.0 ml culture) unless otherwise
indicated. 10'? SRBC or BRBC were added to
appropriate cultures on day 0. Poly A:U was
added with antigen in selected groups as a
positive control. Cultures in each group were
pooled on day 4 and assayed for PFCs.
EXPERIMENTAL RESULTS
In preliminary experiments (C57B1/6 X
C3H)Fi thymocytes were exposed to lethally
irradiated allogeneic (Balb/aj) spleen cells with
or without poly A:U in vitro and the super-
natant fluids tested for their ability to enhance
the PFC response to erythrocytes. Poly A:U-
induced supernatant fluids had only a slight ef-
fect above that induced by allogeneic stimulation
alone. However, supernatant fluids from thymo-
cytes stimulated with poly A:U alone, in the
absence of allogeneic cells, caused significant
PFC enhancement in primary spleen cell cul-
tures. This finding was pursued further, and
optimal conditions for supernatant fluid pro-
duction and assay were established. Normal F^
thymocytes (lO'/ml) were incubated with vari-
ous doses of poly A:U for 10 or 90 min,
washed extensively, and cultured for 6 or 24
h, respectively. Harvested supernatant fluids
were sterilized by filtration and assayed on day
0 by addition at a final dilution of 1:4 to 10^
normal, syngeneic spleen cells with BRBC or
SRBC as antigen. E)irect PFCs were assayed
4 days later. As can be seen in Table I, cultures
of poly A:U-stimulated thymocytes produced
PFC-enhancing supernatant fluids in the ab-
sence of FCS or antigen. The supernatant fluids
resulting from stimulation of thymocytes with
50 /ig poly A:U for as short a time as 10 min,
followed by culture of the washed thymocytes
for 6 h, were capable of a 2.5-fold enhance-
ment of IgM PFC. Increased PFC responses of
normal spleen cells to erythrocytes of two
species suggested that poly A:U-induced super-
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Table II. Kinetics of polyadenylic:polyundylic acid (poly A:U)-induced supernatant fluid (AUSF) production
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* Normal Fi thymocytes were incubated with (AUSF) or. without (control supernatant fluid; CSF) 100 /ng/
ml poly A;U for 10 min, washed four times, and cultured for various periods of time. Supernatant fluids
were added to cultures of normal Fi spleen cells at a 1:4 final dilution with burro erythrocytes (BRBC) as
antigen on day 0. Direct plaque-forming cells (PFCs) were assayed on day 4. Normalized and pooled results
of three experiments are shown. Antilog PFC values are presented in parentheses.
t Compared with group 1.
** Compared with group 2; n.s. = not significant.
t t Compared with groups 2 and 5.
*** Compared with group 7.
natant fluids (AUSF) both acted and were
induced nonspecifically. BRBCs were chosen as
the assay antigen for all subsequent experi-
ments because the background PFC response
was lower to BRBC than to SRBC (allowing
for greater sensitivity in the determination of
PFC enhancement).
Titration of supernatant fluid activity indi-
cated that different lots of AUSF varied in ac-
tivity. A dilution of 1:4 produced a good re-
sponse in most instances and was used in most
experiments. However, occasional lots of AUSF
gave essentially maximal responses at dilutions
of 1:200.
Ki?tetics of poly A:U-induced thymocyte
supernatant fluid production
In other studies of soluble factors from T
cells not induced by poly A:U, optimal en-
hancement usually appeared after 1-2 days in
culture (32). To determine whether poly A:U
altered the kinetics of enhancing-factor produc-
tion by thymocytes, normal Fj thymocytes
(lO^/ml) were incubated with poly A:U for
10 min, washed four times, and cultured for
various periods of time.
Poly A:U stimulated the appearance of en-
hancing factors after only 6 h in culture (Table
II). Normal, nonstimulated thymocytes also
elaborated enhancing factors, but only after 18-
24 h in culture. Supernatant fluids harvested
immediately after exposure to poly A:U (0
time) did not contain enhancing activity.
No significant differences in viability were
observed between control and poly A:U-stimu-
lated thymocytes at any time period. Viabilities
were consistently in the range of 90%-95%
in the 6-h interval. The appearance of enhanc-
ing activity in AUSF was therefore not due to
poly A:U-induced cytotoxicity. An overall rate
of 1%—2%|h loss in viability was observed for
thymocytes in this system.
Enhancement of IgM PPC in vitro by AUSF
To compare statistically the levels of IgM
PFC enhancement with different lots of AUSF,
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Fig. 1. Effect of time of addition of polyadenylic:poly-
uridylic acid (poly A:U)-induced thymocyte super-
natant fluids (AUSF) to primary spleen cell cultures.
Normal Fi thymocytes (lO'/ml) were incubated with
(AUSF) or without (control supernatant fluid; CSF)
50 ^g/ml poly A:U for 30 min, washed four times,
and cultured for 6 h. Supernatant fluids were added
at a 1:4 final dilution on day 0 or day 2 to cultures
of normal Fi spleen cells (lO'/ml) that received
burro erythrocytes as antigen on day 0. Direct and
indirect plaque-forming cells (PFCs) were assayed
on day 4. Mean logio PFC/lO^ viable recovered spleen
cells + SE from three normalized and pooled ex-
periments are presented. All AUSF-stimulated groups
(horizontal stripes) differed from background cul-
tures (BK; open bars) and groups that received only
antigen (AG; vertical stripes) at P < 0.05. As a
positive control, 1.0 jug/ml poly A:U added to culture
with antigen stimulated IgM PFCs (logio 2.78 +
0.26) but not IgG PFCs (logio 0).
the data from 17 experiments were normalized
such that the average PFC response of spleen
cells to BRBC alone was set at 100 PFC/IO^
viable recovered cells (logio 2.00). This value
was chosen because spleen cell cultures re-
producibly responded with 50-150 PFC(10«
viable recovered cells when stimulated by this
antigen alone. Responses of other groups within
the same experiment were adjusted accordingly,
and the average response value was determined
for each like group. With this calculation, con-
trol supernatant fluids from unstimulated
thymocytes had a mean value of 113 ± 25
2.05), and AUSF-supplemented cultures
had a threefold higher mean value of 305 ±
61 (logio 2.48), which is significantly different
at P < 0.05.
Effect of delayed addition of AUSF to spleen
cell cultures
In several systems the induction or enhance-
ment of PFC responses by T-cell factors de-
pends on the time of addition of factor and
antigen (1, 9, 21, 25, 27, 31). We determined
whether AUSF could stimulate PFC responses
also when added to cultures 2 days after an-
tigen. As can be seen in Fig. 1, addition of
AUSF on day 2 enhanced both the IgM and
the IgG responses as well as when added on
day 0. The increase in IgG PFCs, when AUSF
was added on day 0, was variable in these ex-
periments and is not shown. The fact that late
addition of AUSF enhanced both IgM and IgG
PFCs suggests that AUSF may stimulate pro-
liferation of activated lymphocytes.
One of the probable functions of the T cell
in humoral immunity is to control IgG synthesis
(28, 29), and since evidence has been pre-
sented that this cell is a major target of poly
A:U's adjuvant action, the effect of AUSF on
IgG synthesis was determined. It is apparent
from Fig. 1 that AUSF augmented the IgG
response in primary spleen cell cultures rather
dramatically; poly A:U added directly to the
Mishell-Dutton culture system was not capable
of exerting this effect.
AUSF enhancement of secondary
responses in vitro
The relationship between the selective stimu-
lation of T cells by poly A:U and T-cell control
of IgG synthesis suggested that a product of
poly A:U-stimulated T cells might also stimu-
late secondary PFC responses. Accordingly,
AUSF was added with antigen to cultures of
syngeneic spleen cells from mice that had been
primed with 4-8 X 10' BRBC at least 3 weeks
previously. Four days later IgM and IgG PFCs
were assayed. Little residual response remained
in the primed spleen cell population at this
time, inasmuch as the IgM and IgG PFC re-
sponses of the primed spleen cells were lower
before culture than the responses seen subse-
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Table III, Enhancement of secondary plaque-forming
cell (PFC) responses by polyadenylic:polyuridylic
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* BRBC = burro erythrocytes,
t Normal Fi thymocytes (lO'/ml) were incubated
with (AUSF) or without (control supernatant fluid;
CSF) 50 ;itg/ml poly A;U for 30 min, washed four
times, and cultured for 6 h. Supernatant fluids were
added to cultures of BRBC-primed Fi spleen cells
(lO'/ml) at a 1:4 final dilution with BRBC as an-
tigen on day 0, PFCs were assayed on day 4. Mice
were primed with a single injection of 4 X 10*
BRBC 3 weeks before use. Results of one represen-
tative experiment are shown, Antilog PFC values are
shown in parentheses.
quently in background cultures. The data pre-
sented in Table III show that AUSF stimulated
both IgM and IgG secondary PFC responses to
above an already elevated response stimulated
by antigen alone, AUSF caused a two- to four-
fold increase in IgM PFCs compared with
groups receiving control supernatant fluid
(CSF) and antigen or antigen alone, IgG PFCs
also were increased two- to four-fold higher
than groups that received only antigen and
twofold higher than CSF-supplemented cul-
tures. CSF did not stimulate detectable second-
ary IgM PFCs but caused a twofold increase in
IgG PFCs in the experiment shown.
Poly A:U stimulation of peripheral lymphoid
tissue to produce soluble e>7hancing factors
To determine whether poly A:U could stim-
ulate T cells in peripheral lymphoid tissue, as
well as thymocytes, to produce soluble enhanc-
ing factors, spleen cells were incubated with or
without poly A:U for 30 min, washed four
times, and cultured for 6 h. Supernatant fluids,
harvested as before, were assayed in the usual
manner along with AUSF prepared from
Table IV, Comparison of plaque-forming cell (PFC)-enhancing supernatant fluids (AUSF) from polyadenyl-










spleen cells (10^) plus*
Nothing (control)
BRBC
BRBC -t- 1,0 Mg/ml A:U
BRBC -f thymus CSF
BRBC + thymus AUSF
BRBC + spleen CSF
BRBC + spleen AUSF
Mean logio PFC/lO*
viable recovered spleen cells
PFCt
1,40 + 0,11 (25)
2,00 ± 0 (100)
2,82 + 0,09 (660)
2,06 + 0,02 (115)
2,55 ± 0,07 (3^9)
2,19 ± 0,03 (154)








* Normal Fi thymus or spleen cells (lO'/ml) were incubated with (AUSF) or without (control super-
natant fluid; CSF) poly A:U (50 /ig/ml) for 30 min, washed four times, and cultured for 6 h. Harvested
supernatant fluids were added to cultures of normal Fi spleen cells at a 1:4 final dilution with burro eryth-
rocytes (BRBC) on day 0,
t Direct PFCs were assayed on day 4. Results from three normalized and pooled experiments are presented,
Antilog PFC values are shown in parentheses,
** Compared with group 2; n,s, = not significant,
t t Compared with groups 2 and 4,
*** Compared with groups 2 and 6,
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Table V. Failure of polyadenylic:polyuridylic acid (poly A:U)-induced supernatant fluid (AUSF) to stimu-
late T-cell-depleted spleen cells
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BRBC + polyA:U (1.0/ig/ml)









































Cultures of normal or anti-theta- and complement-treated Fi spleen cells received control supernatant
fluid (CSF) or AUSF at a 1:4 final dilution with burro erythrocytes (BRBC) on day 0. Other groups re-
ceived lipopolysaccharide (LPS) or poly A:U and BRBC.
t Direct plaque-forming cells (PFCs) were assayed on day 4. Results from 3 normalized and pooled ex-
periments are presented. Antilog PFC values are shown in parentheses,
t t Compared with groups 2 and 5.
*** Compared with group 8.
thymocytes. It was found (Table IV) that the
degree of PFC enhancement by spleen cell
AUSF was equivalent to that of thymocyte
AUSF, suggesting that AUSF may be a product
of a relatively mature T-cell population.
Whether poly A:U activated cells other than
T cells in the spleen cell population could not
be determined from this experiment.
Failure of AUSF to reconstitute T-cell-deficient
spleen cell cultures
T-cell-depleted spleen cell cultures were
prepared by treatment of normal cells with
anti-theta antiserum and GPC. AUSF was
prepared from syngeneic thymocytes as before
and added to cultures of normal or anti-theta-
treated spleen cells at a 1:4 final dilution with
antigen on day 0. PFCs were assayed 4 days
later. Data presented in Table V indicate that,
whereas AUSF enhanced IgM PFCs in cultures
of normal spleen cells, no such increase oc-
curred in T-cell-depleted cultures. Furthermore,
LPS, added as a positive control, stimulated
IgM PFC formation in normal and T-cell-
depleted cultures, indicating that the B-cell
population was capable of responding. Poly
A:U stimulated only cultures of normal spleen
cells (logio mean 2.57 ± 0.09, not shown).
A similar experiment, using nude spleen cells
on a Balb/c background as a source of T-cell-
deficient spleen cells reaffirmed the inability
of AUSF, from syngeneic thymocytes, to replace
T-cell function (data not shown). In a second
experiment, using a potent AUSF preparation
from Fi thymocytes, there was no stimulation
of PFC formation in cultures of spleen cells
from Balb/c nude mice.
Quantitation of poly A:U content in AUSF
To determine the amount of residual poly
A:U in AUSF, radiolabeled polynucleotide
complexes were used to trace the fate of poly
A:U after thymocyte stimulation.
Poly A:U-Induced T-Cell Factor I l 4 l
Normal Fi thymocytes (10^/ml) were incu-
bated with 50 ;u,g/ml ^H-labeled poly A:U
(61,350 cpm/50 jugi'ml) for 30 min, washed
four times, and cultured for 6 h. After culture,
two centrifugations were performed, and the
resultant supernatant fluids were filter-sterilized
and assayed for radioactive poly A:U content.
AUSF produced in these experiments was
shown to significantly enhance IgM PFCs. The
results (Fig. 2) show that essentially all poly
A:U is removed in the first wash. Negligible
radioactivity appeared in AUSF, equivalent to
0.03 ± 0.01 fig/ml poly A:U. This is 30- to
60-fold less than the lowest concentration of
poly A:U necessary to enhance PFC formation
in our culture system. 48.59 ± 1-19 of the
original 50 /Ag|nil poly A:U could be accounted
for. Consequently, stimulatory amounts of poly
A.U were not present in AUSF.
DISCUSSION
The data presented here demonstrate that poly
A:U stimulation of normal mouse thymocytes
effects the early release of soluble PFC-enhanc-
ing factors into a medium free of both antigen
and serum. This finding clarifies and extends
earlier observations that the adjuvant action
of poly A:U was associated with a decreased
induction period of the immune response with-
out any significant mitogenic action on T cells
(16). Thus, it appears that the function, rather
than the numbers, of T cells is amplified by
this adjuvant. Control supernatant fluids from
nonstimulated thymocytes were able to stimu-
late IgM FFC responses as effectively as AUSF,
but only when the cells producing the factor
were cultured for a longer period of time. A
similar finding with regard to CSF has been
reported by Doria et al. (8). The finding that
a factor was found in the supernatant fluids as
early as 10 min after exposure to poly A:U
and 6 h in culture is also in contrast to the
24-48 h required for the production of T-cell
factors induced after antigenic, mitogenic, or
allogeneic stimulation. Poly A:U thus hastens
the release of what may be a normally occurring











Fig. 2. Polyadenylicipolyuridylic acid (poly A:U)
content in poly A:U-induced supernatant fluid
(AUSF). Normal Fi thymocytes (lOVml) were in-
cubated with 50 |Ug/™l of ^H-labeled poly A;U
(61,350 cpm/50 jug A:U/ml) for 30 min, washed
four times, and cultured for 6 h. After culture, two
centrifugations were performed, and the resultant
supernatant fluids were sterile-filtered and assayed
for radioactive content. Data from triplicate samples
of the supernatant fluids from the centrifugation after
the initial incubation (open bars), washes 1 through
4 (vertical stripes), two centrifugations after 6 h
in culture (stippled bars), and filtered AUSF (hori-
zontal stripes) are presented as the mean logio cpm/
ml + SE. The right-hand ordinate indicates poly
A:U content. 48.59 ± 1.19 of the original 50 jUg/
ml poly A:U were recovered. AUSF contained 0.03
+ 0.01 /ig/ml poly A:U.
Several stimulatory T-cell factors have been
reported to be effective over a narrow time
range, usually the first 24 h of culture, for
optimal activation of PFC responses (14, 21,
24, 30). In our experiments, enhancement of
primary IgM and/or IgG PFC responses was
observed regardless of whether AUSF was
added with antigen at the initiation of the
culture period or 48 h later, indicating that
AUSF may stimulate proliferative instead of
inductive functions. It may be argued that
AUSF, added initially, may persist in the cul-
ture milieu until a later responsive period by
binding to antibody-forming precursor cells,
as has been proposed for the factor described
by Gorczynski et al. ( l4). For secondary in
vitro responses, also only a single addition of
AUSF at culture initiation was necessary.
Schimpl & Wecker (26) have reported that
to stimulate secondary responses, their T-cell
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replacing factor needed to be added daily,
whereas Amerding & Katz (1) found that only
one addition of their factor at culture initiation
was sufficient. These discrepancies may reflect
minor differences in factor stability and con-
centration or may be due to distinct activities
of the respective factors.
The enhancement induced by AUSF was
twice that reported for supernatant fluids from
antigen-primed spleen cells that had been re-
exposed to the priming antigen in vitro and
may be the result of poly A:U polyclonally
stimulating a larger percentage of the thymo-
cyte population than would occur in a clonally
restricted, antigen-induced response (21).
AUSF stimulation of PFC responses was
modest (threefold greater than with antigen
alone). However, it should be noted that AUSF
enhancement occurred in cultures of normal
spleen cells that were capable of mounting a
strong PFC response without AUSF. Therefore,
AUSF should not be expected to stimulate PFC
formation to the degree seen in T-cell-deficient
cultures that had been reconstituted by soluble
T-cell factors (1, 14, 24, 27).
Since cell dilution studies have demonstrated
^ that T cells are limiting in the Mishell-Dutton
system (17), AUSF may have exerted its effect
on T cells. This is supported by the fact that
AUSF was successful at initiating a primary
IgG PFC response in culture, a T-cell-depen-
dent event. Indeed, in light of the failure of
AUSF to reconstitute cultures of anti-theta-
treated or nude spleen cells, its enhancing action
must be considered to be dependent on the
presence of T cells. Gorczynski et al. (14)
have reported a T-cell factor that required a
small population of X-irradiated T cells to
supply an auxiliary function in the stimulation
of anti-theta-treated spleen cells. Schimpl &
Wecker (24) and Armerding & Katz (2) have
reported T-cell factors capable of enhancing
PFC responses but incapable of substituting for
T cells. Thus, some T-cell factors act in concert
with other T-cell helper functions. It is not
known as yet whether AUSF acts on T cells
or whether it may affect the induction and/or
proliferation of B cells, either directly or via
macrophages. If B cells are the target of stimu-
lation, AUSF's demonstrated requirement for
accessory T cells presumably would be for
normal helper T cells. Further experiments are
underway to establish more definitely the cel-
lular site of action of AUSF.
Variation in the amount of AUSF activity,
and its action on IgM and/or IgG PFC re-
sponses, was apparent throughout this study.
For example, approximately 25% of the early
experiments, where IgM alone was measured,
were negative. However, in further studies it
appeared that induction of IgG PFC in primary
cultures was a more stable indicator.
Preliminary characterization of AUSF has
revealed that it is trypsin-sensitive, nondialyz-
able, and resistant to mild heat treatment.
Whereas AUSF activity may have been pre-
sumed initially to be simply due to poly A:U
leached from the thymocytes during culture,
three points of evidence argue against this
possibility: (a) thymocyte cultures that received
poly A:U but were not incubated showed no
significant AUSF activity; (b) poly A:U added
directly to cultured spleen cells with antigen
rarely induced IgG PFC, whereas AUSF did so
consistently; and (c) experiments using radio-
isotopically labeled poly A:U confirmed the
lack of functional amounts of poly A:U in the
supernatant fluids.
T-cell stimulation by poly A:U has been well
documented (18), and the evidence suggests
that poly A:U's main mode of adjuvant action
is through the stimulation of these cells.
Hamaoka & Katz (15) demonstrated that
spleen cells from donors primed with dinitro-
phenyl-keyhole limpet hemocyanin could re-
spond to dinitrophenyl on the heterologous
carrier, bovine gammaglobulin (BGG), in the
presence of poly A:U. Poly A:U stimulation
of this response was abrogated by pretreatment
of the donor spleen cell population with anti-
theta antiserum and complement, demonstrating
the T-cell locus of stimulation. Since poly A:U
failed to augment the adoptive secondary re-
sponse when the hapten was linked to a non-
immunogenic copolymer of D-glutamic acid
and D-lysine (D-G,L), for which few or no
specific T cells could be demonstrated, it was
concluded that poly A:U activated a population
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of BGG-specific, unimmunized T cells in the
donor cell population. However, as is suggested
in the present manuscript, poly A:U activates
thymocytes and peripheral lymphoid T cells in
the absence of antigen and FCS to produce
supernatant fluids with nonspecific enhancing
activity. Thus, T-cell factor release caused by
poly A:U is most likely polyclonal, but the ex-
pression of nonspecific enhancement by AUSF
may be dependent on an undetermined antigen-
specific function of T cells. The hypothesis
that the adjuvant mechanism of poly A:U is the
result of polyclonal T-cell stimulation resulting
in the elaboration of active soluble factors is
consistent with recent findings that poly A:U
(10) or AUSF (11) blocks the induction of
tolerance to soluble BGG in vivo.
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